Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy
Top Cited Papers
Open Access
- 7 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 18 (3) , 482-496
- https://doi.org/10.1093/hmg/ddn376
Abstract
Duchenne muscular dystrophy (DMD) is the most common, lethal, muscle-wasting disease of childhood. Previous investigations have shown that muscle macrophages may play an important role in promoting the pathology in the mdx mouse model of DMD. In the present study, we investigate the mechanism through which macrophages promote mdx dystrophy and assess whether the phenotype of the macrophages changes between the stage of peak muscle necrosis (4 weeks of age) and muscle regeneration (12 weeks). We find that 4-week-old mdx muscles contain a population of pro-inflammatory, classically activated M1 macrophages that lyse muscle in vitro by NO-mediated mechanisms. Genetic ablation of the iNOS gene in mdx mice also significantly reduces muscle membrane lysis in 4-week-old mdx mice in vivo . However, 4-week mdx muscles also contain a population of alternatively activated, M2a macrophages that express arginase. In vitro assays show that M2a macrophages reduce lysis of muscle cells by M1 macrophages through the competition of arginase in M2a cells with iNOS in M1 cells for their common, enzymatic substrate, arginine. During the transition from the acute peak of mdx pathology to the regenerative stage, expression of IL-4 and IL-10 increases, either of which can deactivate the M1 phenotype and promote activation of a CD163+, M2c phenotype that can increase tissue repair. Our findings further show that IL-10 stimulation of macrophages activates their ability to promote satellite cell proliferation. Deactivation of the M1 phenotype is also associated with a reduced expression of iNOS, IL-6, MCP-1 and IP-10. Thus, these results show that distinct subpopulations of macrophages can promote muscle injury or repair in muscular dystrophy, and that therapeutic interventions that affect the balance between M1 and M2 macrophage populations may influence the course of muscular dystrophy.Keywords
This publication has 62 references indexed in Scilit:
- Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophyHuman Molecular Genetics, 2008
- Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesisThe Journal of Experimental Medicine, 2007
- Interplay of IKK/NF-κB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophyJournal of Clinical Investigation, 2007
- Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advancesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivoThe Journal of Physiology, 2006
- Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx miceNeuromuscular Disorders, 2006
- Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growthThe Journal of cell biology, 2003
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- ED2+ Macrophages Increase Selectively Myoblast Proliferation in Muscle CulturesBiochemical and Biophysical Research Communications, 1997
- Improved detection of nitric oxide radical (NO•) production in an activated macrophage culture with a radical scavenger, car☐y PTIO, and Griess reagentFEBS Letters, 1995